Skip to main content
. 2013 Oct 21;13:487. doi: 10.1186/1471-2407-13-487

Figure 4.

Figure 4

Overall survival (OAS) and disease-free survival (DFS) for TNBC patients who received (versus those who did not receive) 100% guideline-adherent adjuvant treatment, as stratified by age (<50, 50–64, and ≥65) and adjusted for year of diagnosis, tumor size, grading, nodal status, menopausal status, and comorbidities.